ASLAN Receives Favorable Opinion on Patent Application for Farudodstat
29 Feb 2024 //
GLOBENEWSWIRE
ASLAN Announces Four Abstracts on Eblasakimab and Farudodstat
24 Apr 2023 //
GLOBENEWSWIRE
ASLAN to Host R&D Day on Novel DHODH Inhibitor Farudodstat
08 Mar 2023 //
GLOBENEWSWIRE